DICERNA PHARMACEUTICALS

EUIPO EUIPO 2018 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark DICERNA PHARMACEUTICALS was filed as Word mark on 11/08/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/21/2019. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 27, 2024

Trademark form Word mark
File reference 017982462
Application date November 8, 2018
Publication date December 12, 2018
Entry date March 21, 2019
Expiration date November 8, 2028

Trademark owner

87 Cambridgepark Drive
02140 Cambridge
US

Trademark representatives

Gedempt Hamerkanaal 257 1021 KP Amsterdam NL

goods and services

5 Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
42 Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Trademark history

Date Document number Area Entry
February 26, 2024 Change Representative, Published
January 7, 2021 Change Representative, Published
January 5, 2021 Change Representative, Published
April 15, 2019 Change Representative, Published

ID: 11017982462